Gregg E. Franklin MD PhD, FASTRO, FACRO, FACR, FASCO
RO Director, New Mexico Cancer Center
Join to View Full Profile
4901 Lang Ave NEAlbuquerque, NM 87109
Phone+1 505-842-8171
Fax+1 505-822-3913
Dr. Franklin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Radiation Oncology, 2001 - 2005
Kaiser Permanente Northern California (Oakland)Internship, Internal Medicine, 2000 - 2001
Tel Aviv University SacklerClass of 2000
Certifications & Licensure
NM State Medical License 2005 - 2027
CA State Medical License 2003 - 2025
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ARIA Medical Oncology EMR, Varian Medical Systems, 2012-2013
Clinical Trials
- Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer
- A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer Start of enrollment: 2018 Jun 19
Roles: Contact
- A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma Start of enrollment: 2022 Sep 21
Roles: Contact
Publications & Presentations
PubMed
- 34 citationsRadiation Therapy for Small-Cell Lung Cancer: ASCO Guideline Endorsement of an ASTRO GuidelineMegan E. Daly, Nofisat Ismaila, Roy H. Decker, Kristin Higgins, Dawn Owen
Journal of Clinical Oncology. 2021-01-27 - 1 citationsNew Landscape: Physician Compensation.Christian A Thomas, Allison M Hirschorn, Julia E. Tomkins, Walter Birch, Linda D. Bosserman
JCO Oncology Practice. 2020-12-22 - 7 citationsRadium-223 (Xofigo) with concurrent abiraterone or enzalutamide: predictive biomarkers of improved overall survival in a clinically advanced cohortJohn Tyler Rathbun, Gregg E. Franklin
Current Problems in Cancer. 2019-06-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
